Robert P. Roche Jr., Director at ANTARES PHARMA, INC. (ATRS), bought 50,000 shares at $0.72 ($36K) on 2016-03-18, disclosed to the SEC on 2016-03-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ATRS | BUY | 2014-08-14 | $10K | — | Filing → |
| PATH | BUY | 2011-09-19 | $27K | — | Filing → |
| CEPH | SELL | 2008-12-23 | $1.8M | — | Filing → |